W. Galetke (Dorsten, Germany), J. Verbraecken (Edegem (Antwerp), Belgium), M. Arzt (Regensburg, Germany)
Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances R. Plywaczewski (Warszawa, Poland)
| |
Monocyte count/HDL cholesterol ratio and cardiovascular disease in patients with obstructive sleep apnea syndrome; a multicenter study H. Inönü Köseoglu (TOKAT, Turkey)
| |
Sleep-disordered breathing is related to Metabolic Syndrome in Outpatients with Diabetes Mellitus Type 2 K. Neumann (Regensurg, Germany)
| |
New opportunities for screening of subclinical atherosclerosis in patients with obstructive sleep apnea (OSA) – a pilot study V. Stratev (VARNA, Bulgaria)
| |
Do glaucoma, nonarteritic ischemic anterior optic neuropathy and sleep apnea march hand in hand? M. Ledina (Sokobanja, Republic of Serbia)
| |
Does sleep apnoea cause acute myocardial injury detectable by biomarkers? N. Tröster (Graz, Austria)
| |
Myocardial alterations in asymptomatic patients with obstructive sleep apnea syndrome P. Gudiel Arriaza (Leon, Spain)
| |
Prevalence and contributing factors for daytime and nocturnal hypoxia in chronic heart failure patients R. Tamisier (Grenoble, France)
| |
Effect of vadaptive servo ventilation on mortality in patients with systolic heart failure and central sleep apnea S. Javaheri (Cincinnati, United States of America)
| |
Whom are we treating with adaptive servo-ventilation? - a clinical post-hoc analysis M. Arzt (Regensburg, Germany)
| |
Cheyne-stokes-respiration is an independent modulator of systolic blood pressure in patients with diabetes mellitus type 2 A. Schreib (Regensburg, Germany)
| |
Is acute pulmonary embolism more severe in the presence of obstructive sleep apnoea? Results from a cohort study. T. Berghaus (Augsburg, Germany)
| |
The prevalence of unrecognized obstructive sleep apnea syndrome among patients with nocturnal symptoms and poorly controlled asthma L. Lo (Hong Kong, Hong Kong)
| |
Frequency and characterization of sleep related disorders in interstitial lung disease patients: a prospective study C. Nicoletta (pontecagnano faiano, Italy)
| |
The impact of severe obstructive sleep apnea and obesity on nonalcoholic fatty liver disease. P. Bielicki (Warszawa, Poland)
| |
Parathyroid Hormone and Vitamin D Levels in Obstructive Sleep Apnea V. Pencheva (Sofia, Bulgaria)
| |
Obstructive sleep apnoea and quality of life in Fabry disease: A parallel cohort study T. Gaisl (Zürich, Switzerland)
| |
Obstructive sleep apnoea and pulmonary involvement in patients with scleroderma T. Yakut (ISTANBUL, Turkey)
| |
Risk for sleep apnea and excessive daytime sleepiness in patients with Myasthenia gravis. E. Oliveira (Sao Paulo, Brazil)
| |
Evaluation of sleep quality and daytime sleepiness in ankylosing spondylitis O. Sengoren Dikis (Van Ercis, Turkey)
| |